HomeCompareUDR vs ELV

UDR vs ELV: Dividend Comparison 2026

UDR yields 5.11% · ELV yields 2.41%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELV wins by $6.66M in total portfolio value· pulled ahead in Year 3
10 years
UDR
UDR
● Live price
5.11%
Share price
$33.66
Annual div
$1.72
5Y div CAGR
19.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.7K
Annual income
$6,549.10
Full UDR calculator →
ELV
ELV
● Live price
2.41%
Share price
$284.79
Annual div
$6.85
5Y div CAGR
81.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.71M
Annual income
$5,527,549.53
Full ELV calculator →

Portfolio growth — UDR vs ELV

📍 ELV pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUDRELV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UDR + ELV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UDR pays
ELV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UDR
Annual income on $10K today (after 15% tax)
$434.34/yr
After 10yr DRIP, annual income (after tax)
$5,566.74/yr
ELV
Annual income on $10K today (after 15% tax)
$204.45/yr
After 10yr DRIP, annual income (after tax)
$4,698,417.10/yr
At 15% tax rate, ELV beats the other by $4,692,850.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UDR + ELV for your $10,000?

UDR: 50%ELV: 50%
100% ELV50/50100% UDR
Portfolio after 10yr
$3.38M
Annual income
$2,767,049.32/yr
Blended yield
81.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ELV right now

UDR
Analyst Ratings
18
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$41.10
+22.1% upside vs current
Range: $38.00 — $44.00
Altman Z
0.7
Piotroski
8/9
ELV
Analyst Ratings
26
Buy
11
Hold
Consensus: Buy
Price Target
$382.64
+34.4% upside vs current
Range: $332.00 — $425.00
Altman Z
2.8
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UDR buys
9
ELV buys
0
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$UDR▼ Sell$15,001 - $50,0002025-10-07
Ro Khanna🏢 House$UDR▲ Buy$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$UDR▼ Sell$1,001 - $15,0002025-09-25
Ro Khanna🏢 House$UDR▼ Sell$1,001 - $15,0002025-08-26
Ro Khanna🏢 House$UDR▲ Buy$1,001 - $15,0002025-07-25
Ro Khanna🏢 House$UDR▲ Buy$1,001 - $15,0002023-11-03
Ro Khanna🏢 House$UDR▼ Sell$1,001 - $15,0002023-10-31
Ro Khanna🏢 House$UDR▲ Buy$1,001 - $15,0002023-10-10
Ro Khanna🏢 House$UDR▼ Sell$1,001 - $15,0002023-09-06
Ro Khanna🏢 House$UDR▲ Buy$1,001 - $15,0002023-08-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUDRELV
Forward yield5.11%2.41%
Annual dividend / share$1.72$6.85
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR19.3%81.2%
Portfolio after 10y$49.7K$6.71M
Annual income after 10y$6,549.10$5,527,549.53
Total dividends collected$25.0K$6.59M
Payment frequencyquarterlyquarterly
SectorREITHealthcare
Analyst consensusBuyBuy
Analyst price target$41.10$382.64

Year-by-year: UDR vs ELV ($10,000, DRIP)

YearUDR PortfolioUDR Income/yrELV PortfolioELV Income/yrGap
1$11,310$609.61$11,136$435.84+$174.00UDR
2$12,870$768.70$12,737$821.90+$133.00UDR
3← crossover$14,746$975.32$15,221$1,592.02$475.00ELV
4$17,024$1,245.96$19,508$3,221.71$2.5KELV
5$19,820$1,603.81$27,866$6,992.55$8.0KELV
6$23,289$2,081.81$46,732$16,915.05$23.4KELV
7$27,647$2,727.39$98,041$48,037.84$70.4KELV
8$33,192$3,609.90$275,572$170,668.09$242.4KELV
9$40,348$4,832.15$1,107,233$812,370.71$1.07MELV
10$49,721$6,549.10$6,712,288$5,527,549.53$6.66MELV

UDR vs ELV: Complete Analysis 2026

UDRREIT

UDR, Inc. (NYSE: UDR), an S&P 500 company, is a leading multifamily real estate investment trust with a demonstrated performance history of delivering superior and dependable returns by successfully managing, buying, selling, developing and redeveloping attractive real estate communities in targeted U.S. markets. As of September 30, 2020, UDR owned or had an ownership position in 51,649 apartment homes including 1,031 homes under development. For over 48 years, UDR has delivered long-term value to shareholders, the best standard of service to Residents and the highest quality experience for Associates.

Full UDR Calculator →

ELVHealthcare

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Full ELV Calculator →
📬

Get this UDR vs ELV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UDR vs SCHDUDR vs JEPIUDR vs OUDR vs KOUDR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.